The Risky Research Review Act would create an independent Life Sciences Research Security Board to review proposed federal funding for high-risk life sciences research. The Board could approve or reject funding and set minimum safety, security, and personnel controls. Agencies and research applicants would have to follow new reporting and review procedures. The bill was introduced and referred to House committees for consideration.
Organizations seeking federal funding for life sciences research would have to report whether their work is high-risk and disclose certain research involving listed agents or toxins. Some proposals could be reviewed by the Board before funding is awarded. Research may have to pause if new circumstances suggest it has become high-risk. The bill does not describe direct effects on individuals outside these research and funding processes.
The bill would authorize $30 million per year for the Board for fiscal years 2026 through 2035. This is authorization to appropriate funds, not a statement that the funds have been provided.
No publicly available information.
No publicly available information.